Projects per year
Search results
-
Active
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S. (PI), Johnston, P. (CoI), Kennedy, R. (CoI), Lawler, M. (CoI), Longley, D. (CoI), Salto-Tellez, M. (CoI) & Wilson, R. (CoI)
01/08/2013 → …
Project: Research